• Thu, May 5, 2022
Tiago Fauth Maintained (APLS) at Hold with Increased Target to $44 on, May 5th, 2022
Tiago Fauth of Credit Suisse, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Hold with Increased Target from $40 to $44 on, May 5th, 2022.
Tiago has made no other calls on APLS in the last 4 months.
There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 0 agree with Tiago's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Tiago
- Elemer Piros of "Roth Capital" Downgraded from Hold to Strong Sell and Held Target at $40 on, Thursday, April 14th, 2022
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $69 on, Monday, April 4th, 2022
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $86 on, Monday, March 7th, 2022
- Timur Ivannikov of "Raymond James" Maintained at Strong Buy with Increased Target to $114 on, Tuesday, March 1st, 2022